Inaction in Fighting Drug Trafficking: Moscow accuses NATO of Waging Undeclared War on Russia
Moscow says the United States and NATO’s inaction in fighting drug trafficking in Afghanistan, translates into an “undeclared war” against Russia.
Russia’s ambassador to NATO, Dmitry Rogozin slammed the alliance for its loose surveillance on drug trafficking out of Afghanistan, the Associated Press reported on Friday.
Afghanistan produces some 90 percent of the world’s opium. The Afghan drugs enter Russia and Central Asia before reaching Western Europe.
Rogozin said the drugs imported from Afghanistan kill 30,000 people in Russia annually, adding that this amounted to “an undeclared war against our country.”
Moscow as well argues that the drug production within the Afghan borders has increased ten times since the 2001 US-led invasion of the country.
There are currently more than 100,000 US-led troopers staged in Afghanistan. The war-weary nation is as well hit with unprecedented levels of violence which is seen as a militant reaction to the sprawling military presence.
Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Center of Research on Globalization grants permission to cross-post original Global Research articles on community internet sites as long as the text & title are not modified. The source and the author's copyright must be displayed. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]
www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the
For media inquiries: [email protected]